Novartis Will Track Gender Disparities In Performance Evaluations Under Settlement
This article was originally published in The Pink Sheet Daily
Gender discrimination suit is resolved with Novartis paying $175 million, 45 percent less than a jury awarded plaintiffs.
You may also be interested in...
Novartis will pay $8m to settle second case; last year Daiichi Sankyo settled gender discrimination class action for the same amount and action against Bayer was dismissed following confidential resolution. Cases are ongoing against Merck and Forest.
Merck is the sixth pharmaceutical company to be hit with a sales rep gender discrimination class action by Sanford Heisler; similar complaints have survived motions to dismiss filed in wake of Supreme Court’s Wal-Mart v. Dukes ruling.
Forest is the fourth pharmaceutical company to face a sales rep gender discrimination class action by Sanford Wittels & Heisler; complaint seeks $100 million in damage as well as changes in pay and promotion.